Return to PJ Online Home Page
The Pharmaceutical Journal Vol 265 No 7117 p529
October 07, 2000 International

World Congress of Pharmacy

Continuing professional development — applying evidence to real people

In a community pharmacy section programme at the FIP congress in Vienna on August 31, participants attended an all-day programme on assessing the quality of various information sources, including internet sources. They also learnt how to integrate “evidence” with advanced clinical judgment to make pharmacotherapeutic decisions for individual patients

The changing role of the pharmacist

Mr Ross Holland (dean, Australian College of Pharmacy Practice), explained that the theme of the session was based around evidence. “Evidence based medicine is the buzz-phrase of the times and we ignore it at out peril.” Although the concept was not new and could be traced back to the mid 19th century in Europe, there were many factors that had catalysed a renewed interest, for example, the staggering growth of medical literature and the increasing complexity of health care.

NHS philosophy
He defined evidence-based medicine as “the conscientious, explicit and judicious use of current best evidence in making decisions about the care of patients,” as reported in the British Medical Journal by Sackett et al in 1996. He told the audience that “evidence-based practice now underpinned the whole NHS philosophy in the UK”.
The rapid expansion and availability of information had impacted on both practitioners and consumers. Busy practitioners did not have time to read and assess the literature and this had led to two developments: meta-analysis databases (Cochrane) and clinical practice guidelines. Consumers, however, received masses of unfiltered and confusing information (increasingly from direct-to-consumer advertising, which reportedly exceeded $1bn) and were often not in a position to evaluate the quality of this information. Promotion of non-prescription products often led to suspect claims and this infinite public access to health information might be a system out of control.
Mr Holland stated that pharmacists had to be able to interpret information to protect the public from errors of understanding and judgment, and it was no longer acceptable to refer requests for information to physicians. “The role of the pharmacist in the future will change from providers of information to interpreters of information,” he concluded.
Later in the session, Mr Holland asked if providing health care information really was easy. “Every time a medication problem arises we simply have to refer to the literature and find out what the evidence base says we should do.” He reminded participants, however, that good doctors “use both the best available external evidence and individual clinical expertise” and that “external evidence alone may be inapplicable or inappropriate for an individual patient”. It was important not to replace individual clinical expertise with external clinical evidence and the integration of both was important for clinical decision making.
He warned against slavishly applying guidelines to all patients and emphasised that clinical guidelines should also be complemented by assessing the individual patient factors when making clinical decisions. Most clinical trial evidence related to highly selected patients with clear-cut indications and no co-morbidity or co-treatment. Most real-life patients might have other conditions as well that also required medication. Therefore, clinical trials were not helpful when trying to assess benefits and risks of individual patient treatment.
Patients’ values and concerns were also becoming important factors in the treatment decision-making process. There was often a discrepancy in the patient’s perceptions of risk and benefit and the physician’s perception of the same, and the increasing role of the patient in therapeutic decision-making made this trade-off more complicated than before.

Fine-tuning
This should not mean that the patient was not provided with the information. What was more important was to ensure that evidence was used properly and to question the values of the policy or “best practice” decision-makers and to be aware of the values driving the evidence-based medicine agenda. Pharmacists, therefore, had to fine tune their problem-solving skills in order to apply their knowledge and clinical judgment to these problems both for health professionals and for patients.